MSB 2.17% $1.13 mesoblast limited

Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval, page-266

  1. 4,028 Posts.
    lightbulb Created with Sketch. 295
    "You are absolutely correct to assert iPSCs can in theory become cancer cells."

    I am glad to see that your data for your SIMILAR ( still laughing ) company, that you holds shares in but haven't contributed on that forum for 2 weeks, has concerns, as a simple search from medical studies will attest to the dangers of iPSC and altered mutant cells produced in the MANUFACTURING process.

    Wow, that certainly doesn't sound similar to anything MSB is doing and sounds novel and complex with severe safety and efficacy issues, but I imagine the FDA will look at that in 10 years when it is submitted, as treatment then will already have a natural treatment that isn't manufactured.

    For the record, you do know that MSB use naturally derived cells? and CYP don't?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.